NPM1 and myelodysplastic syndrome: In fact, the frequency of NPM1-mut in patients with a diagnosis of MDS or myelodysplastic/myeloproliferative neoplasm (MDS/MPN) is low, ranging from 0% to 9% [67,68,69].